*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Levodopa EP Impurity B is a specified degradation product defined in the European Pharmacopoeia for quality control of Levodopa pharmaceuticals. Synthesized via <strong>oxidative decarboxylation</strong>, its molecular formula is C<sub>9</sub>H<sub>11</sub>NO<sub>4</sub> with CAS number 60-71-7.</p>
<h3>Application</h3>
<ul>
<li><strong>Quality Assurance:</strong> Used as reference standards to validate HPLC methods for drug substance testing.</li>
<li><strong>R&D:</strong> Supports stability-indicating assays during formulation development and stress studies.</li>
<li><strong>Regulatory Compliance:</strong> Ensures adherence to ICH guidelines regarding impurity profiling.</li>
</ul>
<h3>Precautions</h3>
<p>Store under inert atmosphere at -20°C to prevent oxidation. Handle with appropriate PPE to avoid skin contact and inhalation. Strictly limit exposure due to potential toxicity associated with catecholamine derivatives.</p>